nobiletin has been researched along with Fatty Liver, Nonalcoholic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 6 (85.71) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Huang, S; Li, S; Li, X; Liu, M; Ning, L; Tu, C; Yan, Y; Zhang, S | 1 |
| Butcher, JT; Fulton, DJ; Larion, S; Mintz, JD; Padgett, CA; Stepp, DW | 1 |
| Fan, C; Ke, Z; Li, H; Li, J; Tian, W; Yu, Q | 1 |
| Deng, Y; Feng, D; Liao, W; Sun, L; Yang, X | 1 |
| Huang, TQ; Jiang, ZM; Li, SZ; Lin, Y; Liu, EH; Yang, X; Yi, Y; Zhang, NN | 1 |
| Bunbupha, S; Maneesai, P; Pakdeechote, P; Prasarttong, P | 1 |
| Choi, MS; Jeong, MJ; Jung, UJ; Kim, SR; Kim, YJ; Woo, JT | 1 |
7 other study(ies) available for nobiletin and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.
Topics: Animals; Apoptosis; Cell Line; Diet, High-Fat; Flavones; Hepatic Stellate Cells; Hepatocytes; Lipid Metabolism; Liver Cirrhosis; Male; Mice; Mice, Inbred BALB C; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Oxidative Stress | 2022 |
The biological clock enhancer nobiletin ameliorates steatosis in genetically obese mice by restoring aberrant hepatic circadian rhythm.
Topics: Animals; Circadian Clocks; Circadian Rhythm; Insulins; Lipids; Luciferases; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Period Circadian Proteins; RNA, Messenger; Tumor Necrosis Factor-alpha | 2022 |
Nobiletin Intake Attenuates Hepatic Lipid Profiling and Oxidative Stress in HFD-Induced Nonalcoholic-Fatty-Liver-Disease Mice.
Topics: Animals; Biomarkers; Diet, High-Fat; Fatty Acids, Nonesterified; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress | 2023 |
A lipidomic study: Nobiletin ameliorates hepatic steatosis through regulation of lipid alternation.
Topics: Animals; Apolipoproteins E; Diet, High-Fat; Lipid Metabolism; Lipidomics; Lipids; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease | 2023 |
Nobiletin Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Gut Microbiota and Myristoleic Acid Metabolism.
Topics: Animals; Diet, High-Fat; Fatty Acids, Monounsaturated; Gastrointestinal Microbiome; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; RNA, Ribosomal, 16S | 2023 |
Nobiletin alleviates high-fat diet-induced nonalcoholic fatty liver disease by modulating AdipoR1 and gp91
Topics: Animals; Antioxidants; Diet, High-Fat; Flavones; Liver; Male; NADPH Oxidase 2; Non-alcoholic Fatty Liver Disease; Rats, Sprague-Dawley; Receptors, Adiponectin | 2021 |
Long-term dietary supplementation with low-dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet-induced obesity.
Topics: Adipose Tissue; Animals; Body Weight; Cytokines; Diet, High-Fat; Dietary Supplements; Dyslipidemias; Flavones; Hepatitis; Insulin Resistance; Lipids; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity | 2017 |